Literature DB >> 9451374

Chromium picolinate supplementation for diabetes mellitus.

G N Fox1, Z Sabovic.   

Abstract

Chromium picolinate is a widely available nutritional supplement marketed for a plethora of afflictions. There is some evidence, including results from human studies, that it has a role in glucose homeostasis. We report the case of a 28-year-old woman with an 18-year history of type 1 diabetes mellitus whose glycosylated hemoglobin (Hb A1c) declined from 11.3% to 7.9% 3 months after initiation of chromium picolinate, 200 micrograms 3 times daily. Chromium picolinate continues to fall squarely within the scope of "alternative medicine," with both unproven benefits and unknown risks. It deserves closer scrutiny with additional prospective, randomized, double-blind, placebo-controlled trials to evaluate its efficacy in improving outcomes in patients with diabetes. A brief review of the literature was done to assist physicians who are being called upon to counsel and treat patients who are engaging in alternative therapies.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9451374

Source DB:  PubMed          Journal:  J Fam Pract        ISSN: 0094-3509            Impact factor:   0.493


  2 in total

1.  Dietary chromium supplementation for targeted treatment of diabetes patients with comorbid depression and binge eating.

Authors:  Kimberly A Brownley; Charlotte A Boettiger; Laura Young; William T Cefalu
Journal:  Med Hypotheses       Date:  2015-03-27       Impact factor: 1.538

2.  Competitive inhibitors of the CphA metallo-beta-lactamase from Aeromonas hydrophila.

Authors:  L E Horsfall; G Garau; B M R Liénard; O Dideberg; C J Schofield; J M Frère; M Galleni
Journal:  Antimicrob Agents Chemother       Date:  2007-02-16       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.